Sponsor pipeline

BlossomHill Therapeutics clinical trial pipeline

Get alerts when BlossomHill Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06706076 A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR… NSCLC (Advanced Non-small Cell Lung Cancer) Recruiting 2026-08-05
Phase 1
NCT06501196 A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk… Leukemia Recruiting 2025-09-24

Disease areas by active trials

Acute Myeloid Leukemia (AML) (1) · Leukemia (1) · Lung Cancer (1) · Myelodysplastic Syndromes (MDS) (1) · Non-Small Cell Lung Cancer (NSCLC) (1)

Get alerts when BlossomHill Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free